← FDA Drug Approvals (Drugs@FDA)

CLARINEX

NDA · New Drug Application · Sponsor: SCHERING · Approved 2002-02-08

Drug application

FDA Application #

NDA021363

Application type

New Drug Application

Brand name

CLARINEX

Generic name

Desloratadine

Active ingredients

DESLORATADINE

Dosage form

Tablet

Route

Oral

Marketing status

Prescription

Sponsor

SCHERING

First approval

2002-02-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown